Gentianella alborosea

Gentianella alborosea (Hercampuri): A Comprehensive Reference

1. Identity and Botanical Classification

Accepted Scientific Name and Synonymy

Gentianella alborosea is a species of flowering plant in the family Gentianaceae. Its currently accepted binomial nomenclature is Gentianella alborosea (Gilg) Fabris. The sole accepted synonym is Gentiana alborosea Gilg, first published in Beibl. Bot. Jahrb. Syst. 118: 55 (1916). The species was formally recombined and published in its current genus by Fabris in 1955 in Bol. Soc. Argentina Bot. 6: 48. The taxonomic hierarchy places it in: kingdom Plantae, order Gentianales, family Gentianaceae, genus Gentianella.

Common Names

The plant is most widely known by the vernacular name Hercampuri (also spelled "Hircampure" or "Hercampure"). Both Gentianella alborosea (Gilg) Fabris and the related species Gentianella nitida (Grisebach) Fabris are widely used in traditional medicine in Peru under the name "hercampuri." This shared common name creates significant identification ambiguity in the marketplace, which is discussed further in the safety section below.

Native Range and Habitat

These small shrubs are native to the high Andes of Peru. The native range of this species is Peru (Junín), and it grows primarily in the subalpine or subarctic biome. Hercampuri originates from Peru, thriving at elevations between 2,800 and 4,300 meters above sea level. The Junín Province is a region of Peru that grows hercampuri.

Morphological Description

The herb grows up to a height of approximately 5 cm and has a rugose and twisted root. The stem is short with a deep brown hue. The dark green, simple leaves measure roughly 1 cm; they are lanceolate, arranged opposite to one another on the stem, and are sessile. The inflorescence is basically cymose, with flowers growing up to 1.5 cm in diameter that are either yellow or pallid lavender, with a small straight-growing peduncle. The roots are thin and yellow in color, and the infusion of hercampuri also has a yellow color.

Gentianella alborosea is considered one of the bitterest herbs in the world. The infusion of hercampuri is one of the most bitter flavors of all herbs.

Common Preparations and Dosage Forms

Hercampuri is traditionally used in herbal medicine as an infusion. The whole plant is used as an infusion. Beyond traditional infusions, the plant is commercially available in dried whole-plant powder form, encapsulated powders, and as tinctures. It has been used as an obesity treatment, in liver diseases, and as a choleretic, cholagogue, and digestive. The aqueous extracts of the whole plant have been used in traditional Peruvian folk medicine as a remedy for hepatitis, as a cholagogue, and in the treatment of obesity.

---

2. Traditional and Historical Use

Pre-Columbian and Incan Traditions

Gentianella alborosea has been used in Peruvian folk medicine since before the time of the Incas. Even the ancient Incas relied on it for treating fevers caused by malaria in Peruvian medicine. This makes it one of the oldest continuously documented medicinal plants of the Andean region, with an uninterrupted record of use spanning at least several millennia.

Quechua and Andean Indigenous Communities

Both species used as "hercampuri" are widely employed in traditional medicine in Peru, mainly to relieve stomach pain, as hepatoprotectives, purifying agents, hypoglycemic agents, diuretics, and for the treatment of obesity and hypercholesterolemia. Ethnobotanical sources documented by the PMC-indexed study from Lima's markets specifically record that Gentianella alborosea was used as a gastric secretion stimulant, an anti-inflammatory (liver), and for blood purification. A separate comprehensive ethnobotanical record notes that Gentianella alborosea was used for diabetes, as a diuretic, and to lower cholesterol.

Preparations Used

Infusions were prepared by adding the flowers, leaves, or stems to boiling water. Traditional preparations also encompassed tinctures and aqueous decoctions from the dried above-ground parts of the whole plant. In herbal medicine, only the above-ground dried parts are used.

Scope of Traditional Indications

Historically documented traditional uses in Peru encompass a wide range of conditions. Based on peer-reviewed ethnobotanical reviews and the PMC-indexed literature:

• Relief of stomach pain and digestive complaints
• Hepatoprotective and "blood purifying" uses
• Hypoglycemic uses (management of diabetes or elevated blood sugar)
• Diuretic applications
• Treatment of obesity and hypercholesterolemia
• Gastric secretion stimulation and anti-inflammatory action targeting the liver
• Treatment of fevers associated with malaria
• Treatment of hepatitis and as a cholagogue

---

3. Key Chemical Constituents

The phytochemistry of Gentianella alborosea has been investigated in a limited number of peer-reviewed studies, with the most definitive phytochemical isolation work published in the journal Phytochemistry and in Fitoterapia. The plant is characterized by several classes of bioactive secondary metabolites.

3.1 Secoiridoid Glycosides

Bitter principles (secoiridoid glycosides) and xanthones are widely distributed among plants belonging to the family Gentianaceae. In G. alborosea specifically, the iridoid glycosides are considered responsible for its characteristic bitterness. The iridoid glucosides of G. alborosea are responsible for the characteristic bitter taste of Gentianaceae. One of them is amarogentin (AG), a secoiridoid glucoside considered the bitterest substance in nature, whose presence in G. alborosea has only been reported by two authors (Singh 2008, Vidari & Vitafinzi 2010). The structure of amarogentin is complex: it can be segregated into three subunits, with the iridoid group (tetrahydropyranone) and the trihydroxybiphenylcarboxylic acid (TBCA) moiety at two opposite ends, linked by a glucose molecule in the middle.

3.2 The Sesterterpenoid Alborosin — A Unique Compound

The most chemically distinctive compound isolated specifically from G. alborosea is a novel sesterterpenoid. The structure of a new type of sesterterpenoid, designated as alborosin, isolated from Gentianella alborosea, was deduced from spectroscopic investigation. This compound was isolated from the CHCl₃ extract of the plant by researchers at Japan's National Institute of Health Sciences (NIHS): the work was published in Phytochemistry in April 2000 (volume 53, issue 8, pages 881–884), with the lead author being N. Kawahara of NIHS, Tokyo, Japan. Alborosin was isolated from the CHCl₃ extract of G. alborosea and occurs in the plant together with xanthones and phenolic compounds.

Alborosin has since been cited in broader natural product chemistry literature. Related sesterterpenoid analogs including 18-epi-alborosin have since been identified in other Gentianella species, confirming alborosin as the founding member of a characteristic sesterterpenoid scaffold for the genus. Sesterterpenoids, biosynthetically derived from the precursor geranylfarnesyl diphosphate (GFDP), are among the rarest of all isoprenoids. Most sesterterpenoids originate from marine organisms, while only about 15% are isolated from plants, including several families such as Lamiaceae, Gentianaceae, and Nartheciaceae.

3.3 Xanthones

The phytochemistry of hercampuri species shows the presence of alkaloids, xanthones, flavonoids, and phenolic compounds, differentiated by the types of secoiridoids and/or sesterterpenes, which are responsible for their biological activity. Xanthones are a hallmark secondary metabolite class of the Gentianaceae family, and they have been identified in G. alborosea by both earlier Italian researchers (Vidari & Vitafinzi, 1991, published in Annali di Chimica) and by subsequent groups. Documented constituents from phytochemical studies include xanthones and alborosin (sesterterpenoid), along with flavonoids and terpenoids.

3.4 Flavonoids, Alkaloids, Saponins, and Glycosides

Phytochemical screening of the methanolic extract of G. alborosea gave positive tests for flavonoids, alkaloids, saponins, and glycosides. These compound classes are consistent with the broader phytochemical profile of the Gentianaceae family and account for several of the plant's historically attributed biological activities, including its choleretic and bitter digestive properties.

---

4. Proposed Mechanisms of Action

The proposed mechanisms underlying the traditional uses of G. alborosea are largely inferred from the known pharmacology of its constituent compound classes, particularly as studied in related Gentianaceae species. No human mechanistic studies have been conducted specifically on G. alborosea.

4.1 Bitter Tonic / Digestive Stimulation

The intense bitterness of the plant, attributed primarily to secoiridoid glycosides including amarogentin, is understood within the bitter-tonic paradigm familiar in European herbal medicine (e.g., Gentiana lutea monographs). Historical records and ethnobotanical studies indicate that indigenous peoples employed hercampuri as a bitter tonic to stimulate appetite, improve digestion, and alleviate gastrointestinal complaints such as bloating and dyspepsia. The traditional use is largely attributed to the plant's bitter principles, which are believed to encourage digestive secretions and promote healthier liver and gallbladder function.

4.2 Choleretic and Cholagogue Activity

On a general level, Gentianaceae species may act on the gallbladder, increasing the flow of bile and its excretion rate. This mechanism, if operative in G. alborosea, would be consistent with its traditional use as a choleretic and digestive aid, though direct mechanistic evidence in this species specifically is not available in the peer-reviewed literature.

4.3 Amarogentin and AMPK Modulation

Anti-inflammatory effects have been attributed to the secoiridoid glucoside amarogentin (AG), which is thought to effectively modulate hepatic metabolism through the activation of AMPK (AMP-activated protein kinase). AMPK activation is a recognized mechanism for improving lipid metabolism and reducing hepatic steatosis in cell and animal models; however, this specific mechanism has been more clearly demonstrated for amarogentin derived from related Gentianaceae species, and its relevance to the specific chemical matrix of G. alborosea extracts remains to be confirmed.

4.4 Antioxidant Radical Scavenging

The antioxidant activity of the plant has been demonstrated in vitro using the DPPH (1,1-diphenyl-2-picrylhydrazyl) free radical scavenging assay. The methanolic extract of G. alborosea was tested for free radical scavenging (DPPH), and the results showed a noticeable radical scavenging activity. This activity is generally attributed to the flavonoid and phenolic content of the extract.

---

5. Scientific Evidence by Area of Use

The overall body of scientific evidence for Gentianella alborosea specifically is sparse. No controlled human clinical trials have been published for this species alone. The available evidence consists of a small number of in vitro cell studies and preclinical animal experiments, plus one key systematic review. Importantly, the 2020 systematic review published in Ethnobotany Research and Applications — which searched Google Scholar, Scielo, Scopus, and PubMed — reached explicitly negative conclusions about the evidence for this species.

5.1 Hepatoprotective Effects

Traditional Claim: The aqueous extracts of the whole plant have been used in traditional Peruvian folk medicine as a remedy for hepatitis and as a cholagogue.

Scientific Evidence: An animal study investigated the effect of G. alborosea extract on non-alcoholic fatty liver disease (NAFLD). The objective was to determine the effect of the extract of Gentianella alborosea as a treatment for NAFLD induced by high-fat diet in female Holtzman rats (published in 2012 in CIMEL: Ciencia e Investigación Médica Estudiantil Latinoamericana). Thirty-two rats were divided into four groups: negative control, positive control, dose 1 (35 mg/kg), and dose 2 (70 mg/kg). NAFLD was induced by high-fat diet (carbohydrates: 26%, lipids: 59%, protein: 15% calories) for 21 days, then an aqueous extract of G. alborosea was administered for 4 days. Significant differences (p<0.05) in the percentage of affected hepatocytes were found between the dose-1 group (3.25 ± 2.27) and the positive control group (7.50 ± 3.76); however, no significant difference was found between dose 1 and dose 2 groups. The study concluded that no clear hepatoprotective effect of the extract was demonstrated, and further studies were strongly recommended.

The 2020 comprehensive review in Ethnobotany Research and Applications summarized the totality of the evidence: G. alborosea has not shown hepatoprotective, hypoglycemic, and lipid-lowering effects, since none of the in vitro and in vivo studies show conclusive results; however, it is safe in the doses used in traditional medicine.

Evidence strength: Weak to inconclusive. Evidence is limited to animal and in vitro studies with null or ambiguous results. No human clinical data exist.

5.2 Antioxidant Activity

Scientific Evidence: The single published, peer-reviewed study on antioxidant activity specifically in G. alborosea was conducted at San Pablo CEU University, Madrid, Spain, published in Fitoterapia (2006): Gentianella alborosea ("Hercampure") was tested for free radical scavenging (DPPH) and induction of apoptosis on a human uterus tumor cell line (HeLa) by its methanolic extract. The results showed a noticeable radical scavenging activity and a dose-dependent apoptotic effect. The plant material (whole plant) was collected in Cuzco, Peru in 2001 and identified by Dr. Galán de Mera; a voucher specimen was deposited in the Herbarium of the School of Pharmacy, San Pablo University, Madrid, Spain.

Evidence strength: Preliminary, in vitro only. A single study using a single extraction method (methanol) and a standard colorimetric (DPPH) assay. No in vivo or human evidence. The study should be considered hypothesis-generating only.

5.3 Pro-Apoptotic / Anticancer Activity

Scientific Evidence: The same 2006 Fitoterapia study by Acero et al. also tested for apoptotic activity in vitro. The methanolic extract was tested for induction of apoptosis on a human uterus tumor cell line (HeLa), and the results showed a dose-dependent apoptotic effect. Several reports have appeared concerning the apoptotic effects of antioxidants, including plant flavonoids that induce apoptosis in some tumor cell lines but not in normal cells; G. alborosea extract was shown to exhibit this property. This in vitro result must be interpreted with extreme caution: HeLa cell-line assays are a standard preliminary screen but do not predict clinical efficacy or safety in cancer patients.

Evidence strength: Highly preliminary; single in vitro study on one cell line. No animal models of cancer have been published. No human data whatsoever.

5.4 Antimicrobial and Anti-Acne Activity

Scientific Evidence: A study found that canchalagua (Schkuhria pinnata), hercampuri (Gentianella alborosea), and corpus way (Gentianella bicolor) had promising antibacterial properties and efficiency against acne. The aqueous and ethanolic extracts of the whole dried plant of Gentianella alborosea were shown to have promising antibacterial properties against acne and possible anti-inflammatory activity.

Evidence strength: Preliminary; in vitro antibacterial assays only. No published clinical trial data for acne treatment. Results are from a multi-herb comparative study.

5.5 Hypoglycemic (Blood Glucose Lowering) Effects

Traditional Claim: Traditional use records list G. alborosea for diabetes and as a diuretic.

Scientific Evidence: Information on the possible efficacy of all the species researched is scarce. Some phytochemical analysis has been done on Gentianella alborosea and the plant was shown to have free radical scavenging properties. None of these studies, however, confirm efficacy as an anti-diabetic. The 2020 systematic review confirmed that G. alborosea has not shown hepatoprotective, hypoglycemic, and lipid-lowering effects since none of the in vitro and in vivo studies show conclusive results.

Evidence strength: No meaningful scientific support for a hypoglycemic effect of this specific species. Evidence base is absent for this indication.

5.6 Lipid-Lowering (Hypolipidemic) Effects

Traditional Claim: Hercampuri is used for the treatment of hypercholesterolemia.

Scientific Evidence: The comprehensive 2020 review concluded that G. alborosea has not shown lipid-lowering effects since none of the in vitro and in vivo studies show conclusive results. This is in contrast to the closely related G. nitida, which did demonstrate lipid-lowering effects in controlled studies.

Evidence strength: Insufficient. No controlled preclinical or human evidence for a cholesterol- or triglyceride-lowering effect specific to this species.

---

6. Body Systems and Health Areas Associated with Gentianella alborosea

• Hepatobiliary system: Historically employed as a hepatoprotective and choleretic/cholagogue agent. This is the most dominant area of traditional use.
• Digestive system: Used as a bitter tonic to stimulate appetite, improve digestion, and alleviate gastrointestinal complaints such as bloating and dyspepsia.
• Metabolic/endocrine system: Applied traditionally for the treatment of obesity and hypercholesterolemia.
• Urinary/renal system: Used as a diuretic in Peruvian traditional medicine.
• Cardiovascular/hematological: Used as a "blood purifier," a broad ethnobotanical category recorded in Lima market surveys, associated with cholesterol lowering and blood pressure.
• Integumentary system: Studied for antibacterial properties against acne-causing bacteria.

---

7. Dosages Reported in Scientific Studies

Reported dosages are exclusively from preclinical (animal) research. No human clinical dosage data have been published in the peer-reviewed literature.

• Ugaz-Soto et al. (2012), NAFLD rat model: Doses of 35 mg/kg (Dose 1) and 70 mg/kg (Dose 2) of aqueous extract were administered to female Holtzman rats.
• Acero et al. (2006), in vitro study: The methanolic extract was prepared at a yield of 2.92% from the dried and powdered plant material. Specific concentrations used in the DPPH and HeLa cell assays were reported in the full-text publication (PMID: 16814959) but are not available in the indexed abstract.

The traditional infusion preparation involves adding the above-ground dried plant material to boiling water, though no standardized quantities are specified in the peer-reviewed ethnobotanical literature for this species in isolation.

---

8. Safety Considerations and Interactions

8.1 General Safety from Traditional Use

G. alborosea is considered safe in the doses used in traditional medicine. This is the primary safety conclusion of the 2020 systematic review published in a peer-reviewed ethnobotanical journal. No reports of serious adverse events have been published in the indexed literature for this specific species at traditional doses.

8.2 Taxonomic Identity Problem — A Documented Safety Concern

A significant and source-verified safety issue concerns the misidentification of plant material sold as "hercampuri." Surveys in Mercado Aviación in Lima yielded four species of Gentianella sold as "Hercampuri." All these species were sold as "Hercampuri." Interestingly, not a single sample of Gentianella alborosea (Gilg) Fabris, the species most commonly mentioned in literature as "Hercampuri," was encountered. This means that consumers purchasing "hercampuri" in Peruvian markets, and potentially in international supplement markets, may be receiving botanically distinct species — including G. nitida, G. thyrsoidea, G. bicolor, or G. incurva — whose safety and efficacy profiles differ. The 2020 review recommends that it would be more advisable to use G. nitida under the name "hercampuri" in traditional medicine, given G. nitida's more robust evidence base for the claimed indications.

8.3 Lack of Human Toxicology Data

While preliminary findings from laboratory and animal research are available, robust clinical trials in humans are still limited. The majority of evidence is derived from laboratory and animal research, and more high-quality human studies are necessary to conclusively validate its efficacy and safety. No published pharmacokinetic, pharmacodynamic, or formal toxicological studies exist for G. alborosea in humans.

8.4 Potential Drug Interactions

No published data on specific drug interactions with G. alborosea extracts or isolated constituents exist in the indexed peer-reviewed literature. The presence of xanthones, which in other Gentianaceae species have been shown to exhibit mild effects on liver enzyme pathways, theoretically warrants attention, but no interaction studies have been conducted or reported for this species.

8.5 Contrasting Evidence with the Closely Related G. nitida

Because both species share the "hercampuri" name and are sold interchangeably, it is important to note that the evidence profiles diverge significantly. In contrast to G. alborosea, G. nitida did demonstrate hypoglycemic, lipid-lowering, antifungal, antibacterial, in vitro antioxidant, and hepatoprotective effects. This distinction is critical for interpreting research on "hercampuri" products in general, as much of the positive pharmacological data in the literature may pertain to G. nitida rather than to G. alborosea specifically.

---

Summary of Evidence Quality

The scientific evidence base for Gentianella alborosea as a dietary supplement and medicinal plant is, as of the most recent comprehensive review (Rubio-Guevara et al., 2020, Ethnobotany Research and Applications), preliminary and insufficient to confirm the efficacy of the plant's major traditional claims. Both species sold as "hercampuri" are used interchangeably, and their main indication is for the treatment of liver diseases, hypercholesterolemia, and diabetes; phytochemistry shows alkaloids, xanthones, flavonoids, and phenolic compounds, differentiated by their secoiridoids and sesterterpenes, which are responsible for their biological activity. However, for G. alborosea itself, the experimental data remain limited to one landmark in vitro antioxidant/apoptosis study (Acero et al., 2006), one negative animal study for NAFLD (Ugaz-Soto et al., 2012), and one chemically significant isolation study confirming the novel sesterterpenoid alborosin (Kawahara et al., 2000). No human clinical trials have been registered or published. The plant's well-documented traditional use continues to motivate further research, but that research has not yet translated into verified clinical evidence.

References

• Rubio-Guevara S, Olascuaga-Castillo K, Blanco-Olano C, Valdiviezo-Campos J. (2020). The ethnobotany and ethnopharmacology of Gentianella alborosea (Gilg) Fabris and Gentianella nitida (Griseb.) Fabris (family Gentianaceae) used in Peru: A review. Ethnobotany Research and Applications, 19, 1–34.
• Acero N, Llinares F, Galán de Mera A, Oltra B, Muñoz-Mingarro D. (2006). Apoptotic and free radical scavenging properties of the methanolic extract of Gentianella alborosea. Fitoterapia, 77(6), 475–477. doi:10.1016/j.fitote.2006.05.020 (PMID: 16814959)
• Kawahara N, Nozawa M, Flores D, Bonilla P, Sekita S, Satake M. (2000). Sesterterpenoid from Gentianella alborosea. Phytochemistry, 53(8), 881–884. doi:10.1016/s0031-9422(99)00518-x (PMID: 10820797)
• Bussmann RW et al. (2013). Peril in the market — classification and dosage of species used as anti-diabetics in Lima, Peru. Journal of Ethnobiology and Ethnomedicine. PMC3738155.
• Acero N et al. (2006). Apoptotic and free radical scavenging properties of the methanolic extract of Gentianella alborosea. Fitoterapia. ScienceDirect record.
• Kawahara N et al. (2000). Sesterterpenoid from Gentianella alborosea. Phytochemistry. ScienceDirect record.
• Ugaz-Soto L, Zafra-Tanaka JH, Tapia Vicente ME. (2012). Efecto de Gentianella alborosea en esteatosis hepática no alcohólica inducida por dieta hiperlipídica en ratas Holtzman hembras. CIMEL: Ciencia e Investigación Médica Estudiantil Latinoamericana.
• Wikipedia. Gentianella alborosea. (Accessed 2025).
• Plants of the World Online (Royal Botanic Gardens, Kew). Gentianella alborosea (Gilg) Fabris. (Accessed 2024).
• GBIF Backbone Taxonomy. Gentianella alborosea (Gilg) Fabris. (Accessed 2024).
• Secoiridoids and xanthones from Gentianella nitida. PubMed PMID: 17252473.
• Rubio-Guevara S et al. (2020). La etnobotánica y etnofarmacología de Gentianella alborosea… Una revisión. ResearchGate full-text.